Protein Tumor Markers
![PDF] Determination of the Reference Values of the Tumor Marker HE4 in Female Population of Canton Sarajevo | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/f50dc44db73d02a0fdaecab49c845d96479f6e8f/3-Table1-1.png "PDF] Determination of the Reference Values of the Tumor Marker HE4 in Female Population of Canton Sarajevo | Semantic Scholar")
PDF] Determination of the Reference Values of the Tumor Marker HE4 in Female Population of Canton Sarajevo | Semantic Scholar
Human Epididymis Protein 4 (HE4) Is a Secreted Glycoprotein that Is Overexpressed by Serous and Endometrioid Ovarian Carcinomas | Cancer Research
HE4, A New Potential Tumor Marker for Early Diagnosis and Predicting of Breast Cancer Progression
![PDF] Determination of the Reference Values of the Tumor Marker HE4 in Female Population of Canton Sarajevo | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/f50dc44db73d02a0fdaecab49c845d96479f6e8f/3-Table2-1.png "PDF] Determination of the Reference Values of the Tumor Marker HE4 in Female Population of Canton Sarajevo | Semantic Scholar")
PDF] Determination of the Reference Values of the Tumor Marker HE4 in Female Population of Canton Sarajevo | Semantic Scholar
Human Epididymis Protein 4 (HE4) mRNA as a Prognostic Marker in Ovarian Tumors in Relation to RMI and CA125 - SciAlert Responsive Version
Marker levels of the adnexal masses 95% CI | Download Table
HE4 reference range in healthy populations according to age or... | Download Table
Serum HE4 and diagnosis of ovarian cancer in postmenopausal women with adnexal masses - American Journal of Obstetrics & Gynecology
Utility of tumor marker HE4 as prognostic factor in endometrial cancer: a single-center controlled study | Semantic Scholar
Tumor Marker Control Specification Sheet - Fujirebio Diagnostics, Inc.
Is HE4 Superior over CA-125 in the Follow-up of Patients with Epithelial Ovarian Cancer? | Bentham Science
InteliQ Tumor Marker Control | Bio-Rad Laboratories
Comparison of Serum Human Epididymis Protein 4 with Cancer Antigen 125 as a Tumor Marker in Patients with Malignant and Nonmalignant Diseases J.M. Escudero, - ppt video online download
Clinical analysis of four serum tumor markers in 458 patients with ova | CMAR
Ovarian Cancer | AACC.org
![PDF] HE4 a novel tumour marker for ovarian cancer: comparison with CA 125 and ROMA algorithm in patients with gynaecological diseases | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/bb4db523eb74d476a02524b225eb0835b20657d2/6-Table3-1.png "PDF] HE4 a novel tumour marker for ovarian cancer: comparison with CA 125 and ROMA algorithm in patients with gynaecological diseases | Semantic Scholar")
PDF] HE4 a novel tumour marker for ovarian cancer: comparison with CA 125 and ROMA algorithm in patients with gynaecological diseases | Semantic Scholar
HE4 tumor marker concentration in neoplastic peritoneal effusion and in peritoneal fluid associated with benign gynecological diseases | Journal of Ovarian Research | Full Text
The biomarker HE4 (WFDC2) promotes a pro-angiogenic and immunosuppressive tumor microenvironment via regulation of STAT3 target genes | Scientific Reports
Tumor Marker Control | Fujirebio
Preoperative HE4 levels and characteristics of patients with epithelial... | Download Table
HE4 is an independent prognostic marker in endometrial cancer patients - Gynecologic Oncology
Clinical analysis of four serum tumor markers in 458 patients with ova | CMAR
Serum human epididymis protein 4 (HE4) as a tumor marker in men with lung cancer
SciELO - Brasil - A comparison of CA125, HE4, risk ovarian malignancy algorithm (ROMA), and risk malignancy index (RMI) for the classification of ovarian masses A comparison of CA125, HE4, risk ovarian
